Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07418502 · ClinicalTrials.gov registry record · Phase 2
Pressure Targeting During High Flow Therapy in Premature Infants
A Phase 2 study, sponsored by University of Texas at Austin.
- Not yet
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
NCT07418502 is a Phase 2 study that has not yet begun recruiting, run by University of Texas at Austin. The registered enrollment target is 78 participants.
The verdict
NCT07418502, a Phase 2 study, has not yet begun recruiting, sponsored by University of Texas at Austin.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
Study Summary
The goal of this study is to see if a new approach to breathing support ('Pressure Targeted High Flow') is as effective as standard of care ('Continuous Positive Airway Pressure') in prematurely born infants. It will also learn about the effect of these types of breathing support on infant comfort and impact on staffing. The main question it aims to answer is: Does Pressure Targeted High Flow provide enough support in premature infants? Participants will: Take spend 24 hours supported by Pressure Targeted High Flow and 24 hours supported by CPAP. During this time their breathing rate, oxygen requirement and other markers of comfort will be monitored.
Interventions
- PROCEDURE CPAP
- PROCEDURE Pressure Targeted High Flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07418502
The ClinicalTrials.gov registry entry for NCT07418502 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CPAP is the first listed.
NCT07418502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07418502 about?
NCT07418502 is a clinical study titled "Pressure Targeting During High Flow Therapy in Premature Infants". The goal of this study is to see if a new approach to breathing support ('Pressure Targeted High Flow') is as effective as standard of care ('Continuous Positive Airway Pressure') in prematurely born infants. It will also learn about the effect of these types of breathing support on infant comfort a...
What is the current status of trial NCT07418502?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2026-05-01. Estimated completion is 2027-09.
What interventions are being tested in trial NCT07418502?
The interventions under investigation include: CPAP (PROCEDURE), Pressure Targeted High Flow (PROCEDURE).
Who is sponsoring clinical trial NCT07418502?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.